TriSalus Life Sciences Inc.

TLSI | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.94

-$0.04 (-0.80%)

Sep 22, 2026, 1:15 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	20.44M	8.53M	11.78M	9.41M	30.3M	4.49M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	400K	350K	n/a	250K	n/a	n/a
Other Long-Term Assets	18K	73K	466K	117K	115K	50K
Receivables	6.56M	5.09M	3.55M	1.56M	1.36M	617K
Inventory	3.08M	4.05M	2.55M	1.47M	1.29M	567K
Other Current Assets	n/a	n/a	n/a	n/a	n/a	406K
Total Current Assets	32.24M	20.67M	20.86M	17.21M	35.13M	6.08M
Property-Plant & Equipment	2.67M	2.88M	3.27M	3.61M	1.8M	1.26M
Goodwill & Intangibles	n/a	n/a	n/a	802K	794K	736K
Total Long-Term Assets	3.09M	3.3M	3.74M	4.78M	2.71M	2.05M
Total Assets	35.33M	23.97M	24.6M	22M	37.84M	8.13M
Account Payables	3M	2.27M	3.39M	4.95M	1.3M	612K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	370K	n/a	42.18M
Other Current Liabilities	2.56M	383K	420K	23.57M	104K	5.22M
Total Current Liabilities	11.5M	10.23M	14.69M	32.36M	6.37M	54.75M
Long-Term Debt	34.27M	22.08M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	23.42M	16.22M	35.73M	369K	561K	3.54M
Total Long-Term Liabilities	57.69M	39.64M	36.98M	1.96M	561K	3.54M
Total Liabilities	69.19M	49.87M	51.66M	34.32M	6.93M	58.29M
Total Debt	34.44M	23.63M	1.6M	1.96M	n/a	42.18M
Book Value	-33.86M	-25.89M	-27.07M	-12.32M	30.9M	-50.16M
Book Value Per Share	-0.89	-0.98	-1.02	-0.42	0.99	-1.64
Common Stock	4K	3K	2K	n/a	11K	8K
Retained Earnings	-330.58M	-279.55M	-249.5M	-186.36M	-136.34M	-107.5M
Comprehensive Income	n/a	n/a	0	n/a	n/a	n/a
Shareholders Equity	-33.86M	-25.89M	-27.07M	-12.32M	30.9M	-50.16M
Total Investments	400K	350K	n/a	250K	n/a	n/a